News

ASCO GU 2026: Blood test predicts which bladder cancer patients may safely skip surgery

ASCO GU 2026: Belzutifan plus pembrolizumab post-surgery helps ccRCC patients at high risk for relapse stay cancer-free longer

ASCO GU 2026: Cancer’s clues in the bloodstream reveal the role androgen receptor alterations play in metastatic prostate cancer

ASCO GU 2026: Hormone therapy may not benefit most men receiving radiotherapy after prostate surgery

Hypertension treatment linked to lower mortality for patients with metastatic breast cancer

Immune cells link lactation to long-lasting health

Fifteen-year results from SWOG S0016 trial suggest follicular lymphoma is curable

FDA grants accelerated approval to zongertinib for unresectable or metastatic non-squamous non-small cell lung cancer

ASCO GU 2026: Enfortumab vedotin pembrolizumab combo may reduce risk of recurrence for some MIBC cases

FDA grants traditional approval to encorafenib for metastatic colorectal cancer with a BRAF V600E mutation

HPV vaccination provides "sustained protection" against cervical cancer

Exercise during chemotherapy for breast cancer measurably improves quality of life